RCOR1 and breast carcinoma: We have recently described corin, a potent and specific dual-warhead inhibitor of the CoREST complex targeting HDAC1/2 and LSD1, that demonstrates growth inhibition in melanoma (16), cutaneous squamous cell carcinoma (16), breast cancers (17), and diffuse intrinsic pontine glioma (18).